Novartis Investigative Site

Aberdeen, Scotland AB25 2ZN

0 studies enrolling now · 3 studies all time

What they study most

Acute Myelogenous Leukemia, Breast Cancer, Multiple Myeloma, Refractory Leukemia

Studies at this site

• Study to Assess the Safety and Efficacy of Ribociclib (LEE011) in Combination With Letrozole for the Treatment of Men and Pre/Postmenopausal Women With HR+ HER2- aBC — Completed
• Panobinostat or Placebo With Bortezomib and Dexamethasone in Patients With Relapsed Multiple Myeloma — Completed
• Efficacy and Safety of Panobinostat (LBH589) in Patients With Refractory de Novo or Secondary Acute Myelogenous Leukemia (AML) — Completed